RecruitingNot Applicable

Effect of Different HPV Education Methods on Vaccination Intention in Young Women

Turkey (Türkiye)117 participantsStarted 2025-12-15

Plain-language summary

Detailed Description Human papillomavirus (HPV) is one of the leading causes of cervical cancer and can be prevented by vaccination. However, HPV vaccination rates among young women are low, largely due to insufficient knowledge and misconceptions about HPV and the vaccine. Therefore, an effective educational program may improve both knowledge and vaccination intention. The aim of this randomized controlled trial is to examine the effect of delivering HPV education through different methods (asynchronous online education delivered via a pre-recorded video and face-to-face education) on HPV knowledge level and HPV vaccination intention among women aged 18-24 years. The study will be conducted with women aged 18-24 years registered at Family Health Centers in the Afşin district of Kahramanmaraş, Türkiye. Eligible participants will be randomly assigned into three groups: the video-based education group, the face-to-face education group, and the control group. Data will be collected using the Participant Information Form, HPV Knowledge Scale, and HPV Vaccination Attitude and Intention Form. Measurements will be performed at three time points: before the education (pre-test), immediately after the education (post-test), and one month after the education (follow-up test). The video-based education group will receive the education via a pre-recorded online video, while the face-to-face group will receive the same content in person at the Family Health Center. No education will be provided to the control group; only measurements will be obtained. Research Questions Does HPV education delivered through different methods increase HPV knowledge levels among young women? Does HPV education increase HPV vaccination intention compared with the control group? Is face-to-face education more effective than video-based education in increasing vaccination intention? Are the improvements in knowledge and vaccination intention sustained one month after the education?

Who can participate

Age range18 Years – 24 Years

SexFEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: Participants must meet all of the following criteria to be included in the study: Aged 18-24 years, Residing in Afşin district, Kahramanmaraş province, Willing to voluntarily participate in the study, Literate and able to understand survey questions in Turkish, Have not previously received the HPV vaccine, Agree to be available throughout the study period (pre-test, post-education test, and 1-month follow-up test), Young women without physical or cognitive impairments or serious health problems that would prevent participation in the study. Exclusion Criteria: Participants will be excluded if they meet any of the following conditions: Under 18 or over 24 years of age, Have received the HPV vaccine or started the vaccine series, Have been diagnosed with HPV infection, Unable to attend the educational sessions or complete all stages of data collection (pre-test, post-education test, 1-month follow-up test), Illiterate or unable to understand the study forms in Turkish, Withdraw from the study or indicate unwillingness to continue participation, Have serious hearing, vision, or cognitive impairments that would prevent meaningful engagement in the educational sessions.

What they're measuring

HPV Knowledge and Vaccination Intention - Pre-Test

Timeframe: Before education

Trial details

NCT IDNCT07420556

SponsorEmel GÜÇLÜ CİHAN

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-01-15

Contact for this trial

Emel Asst. Prof.

03443004913 emel_guclu4606@hotmail.com